Myasthenia gravis often co-occurs with which diseases?

Written by Zhang Hui
Neurology
Updated on November 10, 2024
00:00
00:00

Myasthenia gravis is a type of autoimmune disease of the nervous system, mainly caused by the production of abnormal antibodies in the body. These antibodies affect the acetylcholine receptors in the postsynaptic membrane, thereby impacting the transmission of nerve impulses at the neuromuscular junction. Being an autoimmune disease, myasthenia gravis usually coincides with the following conditions: The first major category is thymus diseases, with most patients experiencing thymic hyperplasia, and particularly, there may be cases of thymoma. If there is a thymoma, it is advised to undergo surgical treatment promptly. The second major category may involve hyperthyroidism, so it is essential to test thyroid function. Thirdly, some patients may also test positive for antinuclear antibodies, which requires careful differential diagnosis.

Other Voices

doctor image
home-news-image
Written by Zhang Hui
Neurology
56sec home-news-image

How to treat myasthenia gravis?

Myasthenia gravis falls under the category of neurological diseases, characterized as an immune disorder of the nervous system, primarily due to the presence of antibodies against acetylcholine receptors. This leads to impaired transmission of nerve impulses to muscles, resulting in various clinical symptoms. The treatment approaches for myasthenia gravis include the following. Firstly, the use of cholinesterase inhibitors is recommended. These medications increase acetylcholine levels and are effective in improving symptoms. Secondly, patients are treated with corticosteroids, typically starting with a low dose and gradually increasing to maintain for a period before reducing the dose again. Adjustments to medication should always be made under the guidance of a neurologist. Third, if the patient has a thymoma, surgical removal is advised.

doctor image
home-news-image
Written by Zhang Hui
Neurology
54sec home-news-image

Myasthenia Gravis Clinical Manifestations

Myasthenia gravis is a type of immunological disease of the nervous system that belongs to neurology. The common clinical manifestations include the following aspects. First, some patients may experience ptosis, where they cannot open their eyes. It usually starts on one side and may also involve abnormal eye movements, such as difficulty in moving the eyes to the left or right, leading to double vision and other clinical manifestations. Second, some patients may experience dysphagia, such as difficulty swallowing, choking on water, and speech articulation disorders. Third, some patients may experience weakness in their limbs, especially an inability to perform strenuous physical activities, such as climbing stairs, which can be significantly affected. These clinical manifestations usually show a pattern of being less severe in the morning and more severe in the evening.

doctor image
home-news-image
Written by Liu Hong Mei
Neurology
50sec home-news-image

Is myasthenia gravis an autoimmune disease?

Myasthenia gravis is an autoimmune disease that primarily affects the neuromuscular junction, leading to abnormalities in acetylcholine receptors. This can cause weakness in some or all skeletal muscles, which easily fatigues, particularly after activity or exertion, with symptoms worsening. Symptoms can be alleviated after rest or treatment with cholinesterase inhibitors. As an autoimmune disease, myasthenia gravis often co-occurs with other autoimmune disorders such as hyperthyroidism, thyroiditis, systemic lupus erythematosus, and rheumatoid arthritis. Symptoms of myasthenia gravis typically lessen in the morning and worsen after activity, showing a pattern of being lighter in the morning and heavier in the evening.

doctor image
home-news-image
Written by Liu Hong Mei
Neurology
58sec home-news-image

Can metronidazole be used for myasthenia gravis?

Patients with myasthenia gravis must use ornidazole with caution and under the guidance of a doctor because the side effects of ornidazole may exacerbate myasthenia gravis. However, ornidazole is not relatively or absolutely contraindicated for patients with myasthenia gravis. Generally, the patient's side effects are observed, and if myasthenia gravis is aggravated, the use of ornidazole is recommended to be cautious or prohibited. Ornidazole can cause neurological reactions, including headache, fatigue, dizziness, trembling, limb numbness and weakness, convulsions, mental confusion, epileptic seizures, ataxia, and consciousness disturbances, and may cause peripheral nerve damage.

doctor image
home-news-image
Written by Liu Yan Hao
Neurology
1min 9sec home-news-image

Does myasthenia gravis hurt?

Myasthenia gravis does not cause pain. Initially, patients with myasthenia gravis may feel discomfort such as soreness or swelling in the eyes or limbs, blurred vision, or fatigue. As the condition progresses, skeletal muscles become noticeably fatigued and weak. A significant characteristic is muscle weakness, which worsens after exertion in the afternoon or evening and improves after rest in the morning, known as "morning better, evening worse." Patients with myasthenia gravis can experience involvement of skeletal muscles throughout the body, manifesting as drooping eyelids, blurred vision, double vision, strabismus, restricted eye movements, bland facial expressions, a "forced smile" appearance, speech impairments resembling a thick tongue often accompanied by a nasal sound. Additionally, they may have chewing difficulties, coughing or choking when drinking, swallowing difficulties, trouble raising the head, weak shoulder shrugging, difficulty lifting arms, combing hair, climbing stairs, squatting, and getting into vehicles, primarily due to muscle weakness, which does not lead to pain.